Circulating metabolites in patients with chronic heart failure are related to increased lipid utilisation but not to gut microbiota alterations

31 August 2024 (15:00 - 15:30)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Andraz Nendl

Oslo University Hospital Ulleval, Oslo (Norway)

4 More presentations in this session

Presentation thumbnail

Is there an association of anthracyclines with HFrEF and/or HFpEF in patients treated for breast cancer or lymphoma after 30 years of follow-up? Insights from the Rochester epidemiology project

Doctor E. Tellez Garcia (Rochester, US)

Abstract Slides Video

Presentation thumbnail

A new heart transplant resource: DBD donor with out-of-hospital cardiac arrest

Doctor G. Fischetti (Bari, IT)

Abstract Slides Video

Presentation thumbnail

Ivabradine prevents doxorubicin-induced cardiotoxicity via attenuating mitochondrial dysfunction and mitochondrial dynamic imbalance in H9C2 cells and rats

Doctor A. Sripusanapan (Chiang Mai, TH)

Abstract Slides Video

Presentation thumbnail

Adipose tissue/ heart lipid transport determines cardiac diastolic function

Mr G. Trimarchi (Berlin, DE)

Abstract Slides Video

Access the full session

Session thumbnail

Miscellaneous clinical studies in heart failure (3)

The Event

Event poster

ESC Congress 2024

31 August 2024 15:00 CET

You may be interested in

Congress Presentation

Gut microbiome-derived metabolites as prognostic biomarkers in heart failure: a systematic review and meta-analysis

Congress Presentation

Interaction of gut microbiota-derived metabolites with inflammatory markers and cellular rejection in advanced heart failure patients treated with heart transplantation

Congress Presentation

Oral microbiome alterations in heart failure: unveiling potential biomarkers and pathways for diagnosis and severity prediction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources